Scrofula natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | |||
[[Category:Tuberculosis]] | [[Category:Tuberculosis]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
{{WH}} | |||
{{WS}} | |||
Revision as of 21:26, 30 November 2012
|
Scrofula Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scrofula natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Scrofula natural history, complications and prognosis |
|
FDA on Scrofula natural history, complications and prognosis |
|
CDC on Scrofula natural history, complications and prognosis |
|
Scrofula natural history, complications and prognosis in the news |
|
Blogs on Scrofula natural history, complications and prognosis |
|
Risk calculators and risk factors for Scrofula natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Prognosis
Prognosis: with adequate treatment, clinical remission is practically 100%. In NTM infections, with adequate surgical treatment, clinical remission is greater than 95%. It is recommended that persons in close contact with the diseased person, such as family members, should undergo testing for tuberculosis.